These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-005266-37 Influence of Escitalopram on the incidence of depression and dementia following acute middle cerebral artery territory infarction. A randomized, placebo-controlled, double blind study. not-yet-due
Ongoing 2006-007090-72 The role of the glutamatergic system in the extinction of conditioned reinforcement processes not-yet-due
Exempt 2007-002245-20 Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers not-yet-due
Ongoing 2007-004286-18 Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) not-yet-due
Ongoing 2007-004309-90 Fahrtüchtigkeit bei Erwachsenen mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) vor und nach 10wöchiger Behandlung mit 40-80 mg Atomoxetin im Vgl. zu unbehandelten Erwachsenen mit ADHS not-yet-due
Ongoing 2012-004079-38 Agomelatine treatment of major depressive episodes in the course of schizophrenic psychoses (AGOPSYCH). A single arm, prospective pilot study Agomelatin zur Behandlung majorer, depressiver Episode... not-yet-due
Ongoing 2012-004335-23 A four-week, multicentre, double-blinded, randomised, active- and placebo-controlled, parallel-group trial investigating efficacy and safety of cannabidiol in acute, early-stage schizophrenic patients... not-yet-due
Not reported 2014-003076-22 Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Su... 2021-01-26 due-trials
Reported results 2018-001212-30 A trial to study effects of a single dose Citalopram on emotion processing in female patients with Borderline Personality Disorder and the associated modulation of fMRI BOLD signals 2019-10-22 due-trials
Ongoing 2019-003984-24 A phase II randomized, double-blind, active placebo-controlled parallel group trial to examine the efficacy and safety of psilocybin in treatment-resistant major depression Eine randomisierte, dopp... not-yet-due